| Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma TN Kreisl, L Kim, K Moore, P Duic, C Royce, I Stroud, N Garren, M Mackey, ... Journal of clinical oncology 27 (5), 740, 2009 | 1828 | 2009 |
| Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy EA Reits, JW Hodge, CA Herberts, TA Groothuis, M Chakraborty, ... The Journal of experimental medicine 203 (5), 1259-1271, 2006 | 1695 | 2006 |
| Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer SB Wedam, JA Low, SX Yang, CK Chow, P Choyke, D Danforth, ... Journal of Clinical Oncology 24 (5), 769-777, 2006 | 663 | 2006 |
| Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy M Chakraborty, SI Abrams, K Camphausen, K Liu, T Scott, CN Coleman, ... The Journal of Immunology 170 (12), 6338-6347, 2003 | 531 | 2003 |
| External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing M Chakraborty, SI Abrams, CN Coleman, K Camphausen, J Schlom, ... Cancer research 64 (12), 4328-4337, 2004 | 506 | 2004 |
| Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer JL Gulley, PM Arlen, A Bastian, S Morin, J Marte, P Beetham, KY Tsang, ... Clinical Cancer Research 11 (9), 3353-3362, 2005 | 425 | 2005 |
| Brain metastases as preventive and therapeutic targets PS Steeg, KA Camphausen, QR Smith Nature Reviews Cancer 11 (5), 352-363, 2011 | 407 | 2011 |
| Radiation therapy to a primary tumor accelerates metastatic growth in mice K Camphausen, MA Moses, WD Beecken, MK Khan, J Folkman, ... Cancer research 61 (5), 2207-2211, 2001 | 352 | 2001 |
| Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro AM McCord, M Jamal, UT Shankavarum, FF Lang, K Camphausen, ... Molecular Cancer Research 7 (4), 489-497, 2009 | 309 | 2009 |
| Radiation abscopal antitumor effect is mediated through p53 K Camphausen, MA Moses, C Ménard, M Sproull, WD Beecken, ... Cancer research 63 (8), 1990-1993, 2003 | 307 | 2003 |
| Enhanced radiation-induced cell killing and prolongation of γH2AX foci expression by the histone deacetylase inhibitor MS-275 K Camphausen, W Burgan, M Cerra, KA Oswald, JB Trepel, MJ Lee, ... Cancer research 64 (1), 316-321, 2004 | 263 | 2004 |
| Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid K Camphausen, D Cerna, T Scott, M Sproull, WE Burgan, MA Cerra, ... International journal of cancer 114 (3), 380-386, 2005 | 257 | 2005 |
| Advances in 4D medical imaging and 4D radiation therapy G Li, D Citrin, K Camphausen, B Mueller, C Burman, B Mychalczak, ... Technology in cancer research & treatment 7 (1), 67-81, 2008 | 245 | 2008 |
| Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration WT Arscott, AT Tandle, S Zhao, JE Shabason, IK Gordon, CD Schlaff, ... Translational oncology 6 (6), 638-IN6, 2013 | 231 | 2013 |
| Optimal scheduling of radiotherapy and angiogenic inhibitors A Ergun, K Camphausen, LM Wein Bulletin of mathematical biology 65 (3), 407-424, 2003 | 220 | 2003 |
| Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity JS Russell, K Brady, WE Burgan, MA Cerra, KA Oswald, K Camphausen, ... Cancer research 63 (21), 7377-7383, 2003 | 217 | 2003 |
| CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines AM McCord, M Jamal, ES Williams, K Camphausen, PJ Tofilon Clinical Cancer Research 15 (16), 5145-5153, 2009 | 209 | 2009 |
| A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma AV Krauze, SD Myrehaug, MG Chang, DJ Holdford, S Smith, J Shih, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 986-992, 2015 | 206 | 2015 |
| Inhibition of histone deacetylation: a strategy for tumor radiosensitization K Camphausen, PJ Tofilon Journal of clinical oncology 25 (26), 4051-4056, 2007 | 194 | 2007 |
| MRI-guided HDR prostate brachytherapy in standard 1.5 T scanner C Ménard, RC Susil, P Choyke, GS Gustafson, W Kammerer, H Ning, ... International Journal of Radiation Oncology* Biology* Physics 59 (5), 1414-1423, 2004 | 191 | 2004 |
